Cargando…
A retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus
Non-intestinal adenocarcinoma of nasal cavity and paranasal sinuses (n-ITAC) is a heterogeneous tumor, which has rarely been reported in previous studies. Most high-grade n-ITAC has poor prognosis and there is a lack of classic therapeutic strategy. The present study examined using the PACS system o...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950340/ https://www.ncbi.nlm.nih.gov/pubmed/36844617 http://dx.doi.org/10.3892/ol.2023.13718 |
_version_ | 1784893141556396032 |
---|---|
author | Li, Jinmei Li, Baofeng Xu, Jin Wang, Huimin Gao, Qingzu Ye, Feng Xu, Yuting Wu, Shuhua Cheng, Shuqiong Lu, Yinghao Guan, Jian Chen, Bei |
author_facet | Li, Jinmei Li, Baofeng Xu, Jin Wang, Huimin Gao, Qingzu Ye, Feng Xu, Yuting Wu, Shuhua Cheng, Shuqiong Lu, Yinghao Guan, Jian Chen, Bei |
author_sort | Li, Jinmei |
collection | PubMed |
description | Non-intestinal adenocarcinoma of nasal cavity and paranasal sinuses (n-ITAC) is a heterogeneous tumor, which has rarely been reported in previous studies. Most high-grade n-ITAC has poor prognosis and there is a lack of classic therapeutic strategy. The present study examined using the PACS system of Nanfang Hospital of Southern Medical University between January 2000 and June 2020. It searched the keyword ‘n-ITAC’ and selected pathology. A total of 15 consecutive patients were searched. Finally, the present study analyzed a total of 12 n-ITAC patients. The follow-up time was 47 months on average. For low-grade (G1) tumors, 1 and 3-year overall survival (OS) rate were 100 and 85.7% respectively, while for high-grade (G3) tumors, 1 and 3-year OS rates were 80.0 and 20.0% respectively. Pathological grade may be an adverse prognostic factor (P=0.077). The OS of the surgery group was significantly superior to that of the non-surgery group (3-year OS was 63.6 vs. 0%, P=0.0009). Surgery is an indispensable means of treatment. The OS of patients with positive incisal margin was lower compared with that of patients with negative margin (P=0.186), suggesting that complete resection may be one of the prognostic factors. Patients with high risk factors received radiotherapy. The radiation dose was 66–70 Gy/33F for patients with positive margin or non-operation and was 60 Gy/28F for those with negative margin. Most of the patients received prophylactic irradiation of cervical area. Therefore, the prognosis of pathological high-grade n-ITAC is poor. Surgery is the most effective and an indispensable treatment for n-ITAC. For patients with high risk factors, surgery combined with radiotherapy may be a reasonable treatment. With regard to the cover range of radiotherapy, the primary tumor combined with lymph node drainage area is often used in Nanfang Hospital of Southern Medical University and the total dose of radiotherapy can be reduced if the surgical margin is negative. |
format | Online Article Text |
id | pubmed-9950340 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-99503402023-02-25 A retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus Li, Jinmei Li, Baofeng Xu, Jin Wang, Huimin Gao, Qingzu Ye, Feng Xu, Yuting Wu, Shuhua Cheng, Shuqiong Lu, Yinghao Guan, Jian Chen, Bei Oncol Lett Articles Non-intestinal adenocarcinoma of nasal cavity and paranasal sinuses (n-ITAC) is a heterogeneous tumor, which has rarely been reported in previous studies. Most high-grade n-ITAC has poor prognosis and there is a lack of classic therapeutic strategy. The present study examined using the PACS system of Nanfang Hospital of Southern Medical University between January 2000 and June 2020. It searched the keyword ‘n-ITAC’ and selected pathology. A total of 15 consecutive patients were searched. Finally, the present study analyzed a total of 12 n-ITAC patients. The follow-up time was 47 months on average. For low-grade (G1) tumors, 1 and 3-year overall survival (OS) rate were 100 and 85.7% respectively, while for high-grade (G3) tumors, 1 and 3-year OS rates were 80.0 and 20.0% respectively. Pathological grade may be an adverse prognostic factor (P=0.077). The OS of the surgery group was significantly superior to that of the non-surgery group (3-year OS was 63.6 vs. 0%, P=0.0009). Surgery is an indispensable means of treatment. The OS of patients with positive incisal margin was lower compared with that of patients with negative margin (P=0.186), suggesting that complete resection may be one of the prognostic factors. Patients with high risk factors received radiotherapy. The radiation dose was 66–70 Gy/33F for patients with positive margin or non-operation and was 60 Gy/28F for those with negative margin. Most of the patients received prophylactic irradiation of cervical area. Therefore, the prognosis of pathological high-grade n-ITAC is poor. Surgery is the most effective and an indispensable treatment for n-ITAC. For patients with high risk factors, surgery combined with radiotherapy may be a reasonable treatment. With regard to the cover range of radiotherapy, the primary tumor combined with lymph node drainage area is often used in Nanfang Hospital of Southern Medical University and the total dose of radiotherapy can be reduced if the surgical margin is negative. D.A. Spandidos 2023-02-14 /pmc/articles/PMC9950340/ /pubmed/36844617 http://dx.doi.org/10.3892/ol.2023.13718 Text en Copyright: © Li et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Li, Jinmei Li, Baofeng Xu, Jin Wang, Huimin Gao, Qingzu Ye, Feng Xu, Yuting Wu, Shuhua Cheng, Shuqiong Lu, Yinghao Guan, Jian Chen, Bei A retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus |
title | A retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus |
title_full | A retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus |
title_fullStr | A retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus |
title_full_unstemmed | A retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus |
title_short | A retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus |
title_sort | retrospective review of non‑intestinal‑type adenocarcinoma of nasal cavity and paranasal sinus |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950340/ https://www.ncbi.nlm.nih.gov/pubmed/36844617 http://dx.doi.org/10.3892/ol.2023.13718 |
work_keys_str_mv | AT lijinmei aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT libaofeng aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT xujin aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT wanghuimin aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT gaoqingzu aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT yefeng aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT xuyuting aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT wushuhua aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT chengshuqiong aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT luyinghao aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT guanjian aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT chenbei aretrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT lijinmei retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT libaofeng retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT xujin retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT wanghuimin retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT gaoqingzu retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT yefeng retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT xuyuting retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT wushuhua retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT chengshuqiong retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT luyinghao retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT guanjian retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus AT chenbei retrospectivereviewofnonintestinaltypeadenocarcinomaofnasalcavityandparanasalsinus |